Department of Medicine, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
Afr Health Sci. 2020 Mar;20(1):324-337. doi: 10.4314/ahs.v20i1.38.
The study sought to determine whether there is any relationship between plasma homocysteine and blood pressure levels in Nigerians with essential hypertension.
It was a cross-sectional analytical study done on 120 randomly selected hypertensive patients and 120 normal healthy controls seen at the large Conference hall of the Ahmadu Bello University (ABU) Medical Centre, Zaria as well as the ABU Teaching Hospital, Zaria, Northern-Nigeria. Pearson's Correlation and Binary Logistic Regression analysis determined the relationship between homocysteine and hypertension.
Hyperhomocysteinaemia found in the hypertensive patients (22.8 ± 6.6 µmol/L) differed significantly (p<0.001) from controls (10.9 ± 2.8 µmol/L) with significant (p<0.001), blood pressure difference between both groups. Homocysteine significantly positively correlated with systolic (r = 0.51, p<0.001) and diastolic (r = 0.47, p<0.001) blood pressures in hypertensive subjects. The relation of plasma hcy to hypertension was statistically significant for SBP; OR: 1.08 (95% CI, 1.05-1.11) and DBP; OR: 1.08 (95% CI, 1.03-1.13) in the unadjusted model. When adjusted for confounding variables, hcy was significantly related to SBP; OR: 1.1 (95% CI, 1.04-1.18) but not DBP (p=0.25; OR: 1.06 (95 % CI, 0.96-1.18). The mean plasma folate level was high (115.2 ± 48.0 ng/mL) in the hypertensive subjects. The hyperhomocysteinaemic subjects showed a 2.8 times Odds of developing hypertension.
This study showed higher mean plasma homocysteine levels in hypertensives than controls not accounted for by sub-optimal folate levels. Hyperhomocysteinaemia showed a positive relationship to systolic hypertension after adjusting for confounders.
本研究旨在确定原发性高血压患者血浆同型半胱氨酸水平与血压之间是否存在关系。
这是一项横断面分析研究,在尼日利亚扎里亚的阿布贾大学(ABU)医学中心大会堂以及 ABU 教学医院共纳入 120 例随机选择的高血压患者和 120 例正常健康对照者。Pearson 相关分析和二元逻辑回归分析确定了同型半胱氨酸与高血压之间的关系。
高血压患者的高同型半胱氨酸血症(22.8±6.6µmol/L)与对照组(10.9±2.8µmol/L)有显著差异(p<0.001),两组之间的血压差异有统计学意义(p<0.001)。同型半胱氨酸与高血压患者的收缩压(r=0.51,p<0.001)和舒张压(r=0.47,p<0.001)呈显著正相关。在校正混杂因素后,血浆 hcy 与高血压的关系具有统计学意义,SBP:OR:1.08(95%CI,1.05-1.11)和 DBP:OR:1.08(95%CI,1.03-1.13)。在校正混杂因素后,hcy 与 SBP 显著相关,OR:1.1(95%CI,1.04-1.18),但与 DBP 无关(p=0.25;OR:1.06(95%CI,0.96-1.18)。高血压患者的平均血浆叶酸水平较高(115.2±48.0ng/mL)。高同型半胱氨酸血症患者发生高血压的几率是正常同型半胱氨酸血症患者的 2.8 倍。
本研究显示高血压患者的平均血浆同型半胱氨酸水平高于对照组,这不能用亚叶酸水平不足来解释。在校正混杂因素后,高同型半胱氨酸血症与收缩期高血压呈正相关。